Creating the Prescription Drug Affordability Board

HB 2831 creates the West Virginia Prescription Drug Affordability Board to address high prescription drug costs. The board will directly affect West Virginia residents, state/local governments, commercial health plans, healthcare providers, and pharmacies by reviewing drug pricing. Key provisions include establishing the board with appointed members (including experts in health care economics), requiring a cost review process for drugs with affordability challenges, and creating an advisory Stakeholder Council. The bill also defines key terms like "brand name drug" and "manufacturer," and mandates transparency reports while requiring conflict-of-interest disclosures.